Press resources, speaker materials, and media kits

Steven Thompson is the Founder & CEO of NexTrial.ai, building the activation infrastructure clinical trials never had. With Celina as AI coordinator and Country Blueprints spanning FDA, ANVISA, and CDSCO, NexTrial compresses trial activation from 120 to 30 days. Presenting at DIA 2026.

Steven Thompson is the Founder & CEO of NexTrial.ai, where he's building physics-informed AI that compresses clinical trial activation from 120 to 30 days across FDA, ANVISA, and CDSCO jurisdictions. The platform's Predict → Activate → Prove framework, powered by Celina as AI coordinator and Country Blueprints encoding 6-12 months of regulatory knowledge per jurisdiction, achieves 94% first-submission approval rates vs. 70-75% industry standard. Steven is presenting at DIA 2026 (Abstract ID 116114). Currently, he also delivers enterprise transformation consulting through Think People within the Oliver Wyman ecosystem, including Paramount Studios Project Fusion. With $1.2B+ in delivered programs and operations spanning the US, Brazil, and India, Steven turns regulatory complexity into competitive advantage.

Steven Thompson is the Founder & CEO of NexTrial.ai, an AI-native platform transforming how clinical trials activate and scale globally. The platform's Predict → Activate → Prove framework compresses trial activation from 120 to 30-45 days—a 58% improvement demonstrated in pilots across 12 trials. NexTrial's architecture includes Celina, an AI coordinator that sends verified Schedule of Activities and recruitment plans to CTMS/EDC systems, then reads execution signals back. Country Blueprints encode 6-12 months of regulatory knowledge per jurisdiction (FDA, ANVISA, CDSCO), creating an 18-36 month replication barrier. The platform's Zero-Rejection Architecture validates every packet before submission with deterministic verification—proof certificates, not confidence scores—achieving 94% first-submission approval rates vs. 70-75% industry standard. Steven brings over 15 years of experience orchestrating billion-dollar transformations across life sciences, financial services, and agriculture. At ADM, he led a >$1.2B global ERP transformation delivering $250M in cost savings across 44,000+ employees. At NuBank, he architected HCM systems scaling from 700 to 10,000+ employees for IPO readiness. His GxP data engineering at Takeda and Biogen established the compliance-first principles now embedded in NexTrial.ai. Currently, Steven also delivers enterprise transformation consulting through Think People within the Oliver Wyman ecosystem, including Paramount Studios Project Fusion. He's presenting at DIA 2026 Annual Meeting (Abstract ID 116114, Track 02) in Philadelphia. Based in São Paulo with operations spanning the US, Brazil, and India, Steven runs on AI-native infrastructure—a coordinated team of AI agents handling competitive intelligence, investor research, regulatory monitoring, and content production. This isn't aspiration; it's production infrastructure enabling a lean team to move at a pace that doesn't make sense to competitors still running on email and spreadsheets.